JAK Inhibitors in Rheumatoid Arthritis: Overcoming Challenges and Maximizing Impact

episode

Keeping Current CME not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Russia’s New Drone Threat Raises Alarms in Ukraine 21 min · 27 Sep 2026 · The MeidasTouch Podcast

FULL SHOW: Evict My House Guest Awkward, Whatcha Doin’ at Oktoberfest + Prison Prank (9/22/26) 55 min · 27 Sep 2026 · Brooke and Jeffrey: Second Date Update

The Inherited Mindset: Firing Your Family’s Financial Beliefs 3 min · 27 Sep 2026 · The Level Up Podcast w/ Paul Alex

The Rise of the AI Moderates 32 min · 27 Sep 2026 · The AI Daily Brief: Artificial Intelligence News and Analysis

NPR News: 09-27-2026 7AM EDT 5 min · 27 Sep 2026 · NPR News Now

7AM ET 09/27/2026 Newscast 3 min · 27 Sep 2026 · Fox News Hourly Update

Report any issue

Source

Recorded11 Dec 2025

Publisherkeepingcurrentcme.libsyn.com ↗

Handlerec:14540777

Show notes

See where Janus kinase (JAK) inhibitors fit into rheumatoid arthritis (RA) treatment to tackle obstacles and improve patient outcomes. Credit available for this activity expires: 12/10/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/[articleID]?ecd=bdc_podcast_libsyn_mscpedu

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in